The utility of the Edmonton Obesity Staging System for the prediction of COVID-19 outcomes: a multi-centre study.

ABSTRACT:

Background

Patients with obesity have an increased risk for adverse COVID-19 outcomes. Body mass index (BMI) does not acknowledge the health burden associated this disease. The performance of the Edmonton Obesity Staging System (EOSS), a clinical classification tool that assesses obesity-related comorbidity, is compared with BMI, with respect to adverse COVID-19 outcomes.

Methods

1071 patients were evaluated in 11 COVID-19 hospitals in Mexico. Patients were classified into EOSS stages. Adjusted risk factors for COVID-19 outcomes were calculated and survival analysis for mechanical ventilation and death was carried out according to EOSS stage and BMI category.

Results

The risk for intubation was higher in patients with EOSS stages 2 and 4 (HR 1.42, 95% CI 1.02-1.97 and

SUBMITTER: Rodriguez-Flores M 

PROVIDER: S-EPMC8873002 | biostudies-literature | 2022 Mar

REPOSITORIES: biostudies-literature